PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Qingchangligan formula alleviates acute liver injury by attenuating extracellular histone-associated inflammation.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29649629 ↗2018Reported benefit

Qingchangligan formula alleviates acute liver injury by attenuating extracellular histone-associated inflammation.

MouseChemical/toxinC57BL/6Male

Model: Concanavalin A-induced acute immune-mediated liver injury in mice, with parallel histone-induced damage in HL-7702 human hepatocytes and an observational clinical arm in acute-on-chronic liver failure patients

QCLGF improved survival in Concanavalin A-treated mice, reduced hepatotoxicity and lowered extracellular histones and associated cytokines, with inhibition of MAPK signalling. QCLGF also prevented histone-induced HL-7702 cell damage, and acute-on-chronic liver failure patients receiving QCLGF in ad…

Extraction: extract · Supplied extraction confidence: 0.5. Machine-extracted fields require source verification.